126
Participants
Start Date
July 24, 2024
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2030
1.0% IP-001 for injection
Participants will receive a single injection of 1.0% IP-001 following local ablation or surgical resection and local ablation
Surgical Resection and Local Ablation
Participants will undergo surgical resection of the tumor and local ablation by either radiofrequency ablation (RFA ) or microwave ablation (MWA)
Local Ablation Alone
Participants will have local ablation of the tumor by either radiofrequency ablation (RFA) or microwave ablation (MWA) alone
RECRUITING
University of Louisville, Louisville
Robert C. Martin
OTHER